All approvals received for OPACE trial!
As of 26th Sep 2023, we are pleased to confirm final approvals have been received from the Medicines and Healthcare products Regulatory Agency (MHRA), the Research Ethics Committee (REC), and Health Research Authority (HRA) for the OPACE trial to proceed.
What happens next?
Following approvals, we can start initiating and activating sites to begin the recruitment process. The first site to be recruited will be here at Cambridge University Hospitals (CUH) NHS Foundation Trust with an initiation meeting due to take place in November 2023. This meeting will ensure trial staff receive full trial procedure and regulatory requirement training to begin patient recruitment. Following activation of CUH as the first site, collaborator sites can then be initiated and activated in wave 1 of the recruitment process.
Secondary care sites: OPACE Early Expression of Interest Form for Secondary Care/Hospital Sites (google.com)
Primary care sites: OPACE Early Expression of Interest Form for Primary Care/ GP Sites (google.com)
Further updates to follow!